Lisdexamfetamine Capsules and Pasireotide Extended-Release Injection
Determining the interaction of Lisdexamfetamine Capsules and Pasireotide Extended-Release Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lisdexamfetamine
Brand name: Vyvanse
Synonyms: Lisdexamfetamine
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lisdexamfetamine Capsules-Pasireotide Injection
- Lisdexamfetamine Capsules-Pasireotide Subcutaneous
- Lisdexamfetamine Capsules-Patanase
- Lisdexamfetamine Capsules-Patiromer
- Lisdexamfetamine Capsules-Patiromer Sorbitex Calcium
- Lisdexamfetamine Capsules-Pavacot
- Pasireotide Extended-Release Injection-Lisdexamfetamine Chewable Tablets
- Pasireotide Extended-Release Injection-Lisdexamfetamine dimesylate
- Pasireotide Extended-Release Injection-Lisinopril
- Pasireotide Extended-Release Injection-Lisinopril and Hydrochlorothiazide
- Pasireotide Extended-Release Injection-Lisinopril Oral Solution
- Pasireotide Extended-Release Injection-Lisinopril Tablets